Search
for
Sort by
Research 30 of 1000+
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Advancing Design Strategy of PROTACs for Cancer Therapy
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- PROTACs: A novel strategy for cancer drug discovery and development
- Clinical Translation of Targeted Protein Degraders
- De novo designed bifunctional proteins for targeted protein degradation
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
- Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera.
- Potent Efficacy of Computer-Aided Designed Peptide Degrader Drug on PCSK9-Mediated Hypercholesterolemia
- The role of hair follicles and Edar signalling in cutaneous wound healing
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- CD44 signaling in skin wound healing and regeneration
- β-Catenin Signaling Evokes Hair Follicle Senescence by Accelerating the Differentiation of Hair Follicle Mesenchymal Progenitors
- Updates in Treatment for Androgenetic Alopecia
- Microneedle-Based Approaches for Skin Disease Treatment
- Artificial Intelligence in Hair Disorders: A Narrative Review